User:Cnoellec49/Undertreatment of pain
Affected Populations
[edit]Undertreatment of pain is common and is experienced by all age groups, from neonates to the elderly.[1][2] In September 2008, the World Health Organization (WHO) estimated that approximately 80 percent of the world population has either no or insufficient access to treatment for moderate to severe pain.[3] Every year, tens of millions of people globally, including around four million cancer patients and 0.8 million HIV/AIDS patients, suffer from lack of pain relief as part of their end-of-life treatment.[4] Yet the medications to treat pain are cheap, safe, effective, and generally straightforward to administer, and international law obliges countries to make adequate pain medications available.[4]
Pain, particularly chronic pain, is understood via a constellation of factors, specifically pathopsychology, cognitive, affective, behavioral and sociocultural factors.[5] As such, the adequate treatment of pain requires a multidisciplinary approach that accounts for how chronic pain is experienced differently among patients of differing cultures and ethnicities.[5] (Teak)
Some pain patients are made invisible through the limited representation of people of color in clinical research, the marketing of analgesics, and biases among healthcare practitioners leading their pain to be ignored.[6] While decades of pain research have neither produced a clear and consistent pattern of sex difference in human pain tolerance,[7] nor substantiated “fantastical” claims about racialized pain tolerance,[6] biases within the medical sphere persist in ways which disenfranchise minoritized patients causing the undertreatment of pain. (Teak)
Race
[edit]Literature examining the medical field indicates disparities in pain care for racial and ethnic minorities.[8] Compared to Caucasian patients, African American and Hispanic patients are particularly at risk for being undertreated for pain.[8] There are a variety of conditions for which African Americans and other racial and ethnic minorities experience continuous undertreatment, including cancer pain, acute postoperative pain, chest pain, acute pain, and chronic low back pain.[8] Research demonstrates that even when controlling for age, gender, and pain intensity, racial and ethnic minorities are frequently subjected to insufficient treatment for acute and chronic pain when compared to non-Hispanic whites.[9] A study examining over 1300 non-minority and minority patients discovered that those at facilities with principally minority patients were three times more likely to be undermedicated than patients treated in non-minority facilities. Furthermore, a follow-up study that investigated pain treatment in minority patients with recurrent or metastatic cancer found that 74% of Latinx and 59% of African American patients experiencing pain were not given the adequate analgesics.[10] Minority patients, when compared to non-minority patients, were not as likely to be appropriately evaluated for their pain and reported less pain relief.[10] Although the prescription of opioid analgesics in response to pain-related visits grew from 1993 to 2005, disparities in prescribing to racial and ethnic minorities persisted. White patients experiencing pain were considerably more likely to be prescribed an opioid analgesic when compared to Black, Hispanic or Asian patients. Specifically, 40% of white patients were prescribed opioid analgesics in 2005, while only 32% of nonwhite patients experiencing pain were prescribed them.[10]
Sickle Cell Disease (Amy)
[edit]Around 100,000 Americans are affected by sickle cell disease (SCD), the majority of whom are of African or Hispanic descentf, and half of the adults with SCD don’t survive past their early-40s.[11] A characteristic feature of SCD is pain crises, or episodes of pain, which can vary in frequency and severity among individuals; sickle cell pain can be a sign of a lack of oxygen delivery to vital organs (vaso-occlusive crisis), which can lead to organ damage and death.[11][12] Pain itself can exacerbate the severity of the disease as it causes blood vessels to constrict and further prevents proper oxygen circulation in the body.[11][13]
Disparities in access to treatment and quality of care affect those with SCD, particularly treatment for pain relief.[13] Sickle cell patients often face delayed care in emergency rooms, with patients at one hospital found to have 60% longer wait times to get pain medication compared to those with less severe symptoms of pain.[11] Inadequate training of doctors and nurses to treat SCD is another contributing factor to undertreated pain in this population of patients: medical schools often offer very little sickle cell education, resulting in physicians who don’t know how to properly care for sickle cell patients.[11][14] In a survey of 3,000 family physicians, only 20% claimed they felt confident in treating the disease, meaning many cannot provide appropriate routine care for individuals with SCD.[11] Furthermore, access to specialists and SCD treatment centers is difficult for many patients. Health insurance policies may prevent patients from seeing the specialists equipped to deliver quality care for SCD, and hematologists and treatment centers who specialize in SCD are scarce in general, adding a further barrier for patients to find care within an accessible distance.[11][15]
Racial stereotyping and the opioid crisis have made physicians more hesitant to give opioid medication to sickle cell patients presenting with pain.[11][14] Those in acute sickle crises are often seen as drug seeking because many doctors are trained to look out for the following behaviors: asking for a specific opioid medication, returning many times for the same issue, having complaints that are “out of proportion,” and seeking treatment at a hospital.[11] Sickle cell patients often are very familiar with their treatment plans and which medications work for them; yet, doctors are also often suspicious of patients who know too much about the pain medications they need.[11] Furthermore, SCD patients usually require higher doses as they build tolerance towards the drug, making doctors who aren’t familiar with the case even more unlikely to trust the patient and provide necessary care.[11] Overall, however, there is not a lot of evidence showing particularly high rates of addiction among sickle cell patients: one study found stable opioid use among SCD patients over time while rates of use and addiction have increased in America.[15] Nevertheless, practices have been put in place to prevent opioid dependence among sickle cell patients: rather than giving injections of hydromorphone, many hospitals have instituted a new protocol that delivers hydromorphone in a diluted form using IV drips; the slower medication delivery leaves SCD patients experiencing severe crises still in pain.[15]
Hydroxyurea, originally to treat cancer, is an oral drug that can also effectively and safely reduce pain crises in sickle cell patients by increasing quantities of normal red blood cells, yet it’s often underprescribed and underutilized; reasons include barriers to obtaining refills, need for management and follow up visits, and side effects, including reduction in white blood cells.[11][13] Fewer than 25% of adult patients who need hydroxyurea to prevent pain crises actually are able to receive it outside the hospital.[11][13]
Gender
[edit]There are disparities in the quality of healthcare between sexes and genders, and because pain is one of the most common reasons for people to seek healthcare, there are disparities in the treatment of pain. While research has not produced a clear and consistent pattern of sex difference in human pain sensitivity,[7] research suggests that there are biological differences in the experience of pain both along biological sex lines and along gender identity lines. There is also evidence to support that social expectations about the expression of pain can dictate patient and doctor responses, linking the treatment of pain to social stereotypes. However, historically, women have been underrepresented in clinical studies, meaning that their experience of pain and their reaction to various medications is less understood. Additionally, chronic pain, and conditions of chronic pain, are more common in women, but the rates of chronic pain and the differences in experience between men and women are not well documented. Chronic pain in women may also be attributed to reproductive issues or mental health, even when these are not causes.
Causes (Cambria)
[edit]Europe
[edit]Research conducted in Europe for the Journal of Pain & Palliative Care Pharmacotherapy has found that undertreatment of chronic pain in patients is widespread and is tied to legislative controls that regulate opioid prescription, which in turn creates fear of prescribing in providers. Patients are also hesitant to take opioids due to fear of dependency. [16]
India
[edit]A case study published in the Journal of Pain Research revealed that in India, standardized pain management plans, which are designed to prevent pain mismanagement, are often not followed by doctors. Many physicians cited fear of addiction or dependence as a reason for their hesitancy to prescribe opioids, even when indicated. In addition, they found that several other cultural factors influenced the patient’s adherence to pain plans. These included fear of opioid dependence, fear of questioning authority, and the cultural belief that suffering is a part of illness and therefore should be faced with stoicism.[17]
The article also noted that similarly to the United States, several specific populations were found to have more issues with undertreatment of pain, including children, the elderly, and those with renal or hepatic dysfunction. Concerns with the elderly are often due to the prevalence of multiple comorbidities that make pain difficult to manage. Children often have communication barriers and neonates may be assumed not to feel pain. Many drugs are activated and excreted through the liver or kidney, so when there is hepatic or renal illness, pain medication dosing needs to be adjusted in a way that isn’t always standardized.[17]
Latin America
[edit]Similar to the United States and India, fear of prescribing opioids is a main reason cited for ineffective pain management in Latin America. A study in Pain Management notes that there is an overuse of nonopioid analgesics in Latin America due to this hesitancy that can be traced back to lack of training of physicians and health care providers. Other barriers to access include limited access to healthcare. Undertreatment of pain is widespread due to both the lack of access to opioids, which results in moderate to severe pain being managed with nonopioid analgesics that are not as effective, and fear of prescribing opioids when available.[18]
Consequences (Amy)
[edit]![](http://upload.wikimedia.org/wikipedia/commons/thumb/3/3a/Healthcare_costs.jpg/220px-Healthcare_costs.jpg)
Inadequate pain management can leave several lasting impacts on individuals, such as a decreased quality of life (QOL).[14] Higher pain severity has been found to be associated with lower self-reported evaluations of mental and physical wellness, negatively affecting a wide range of QOL components, including sleep, mood, mobility and physical functioning, sexual relationships, and social life.[14] Individuals with chronic pain are more likely to have psychiatric illnesses, such as depression, anxiety, and post-traumatic stress disorder.[19]
Lack of postsurgical pain relief leads to higher healthcare costs as recovery time and hospital stays are prolonged.[14] Undertreatment of symptoms of pain in sickle cell patients, for instance, can give rise to millions of dollars per year directed towards more frequent emergency room visits, hospitalizations, as well as the costly effects of lost work productivity.[12] The timely and appropriate treatment of pain, thus, can reduce economic burdens and, because pain is one of the primary reasons for hospital readmissions, significantly lower the prevalence of patients who need to return for more care.[14]
Undertreated acute pain may also have more lasting physiological consequences and further contribute to healthcare spending that’s avoidable. Severe pain can interfere with a patient's respiratory and cardiovascular physiology with increased risks of respiratory infection, myocardial ischemia, infarct or cardiac failure, and thromboembolic disease, impeding the patient's ability to recover and be discharged.[19] Studies on patients hospitalized for issues ranging from childbirth to burn injuries to breast surgery to other serious illnesses have also all pointed to more intense acute pain levels being a risk factor for the development of chronic pain; the evidence indicates that insufficient treatment of acute pain doesn’t only have temporary consequences for patients, but potentially also a decreased QOL for the rest of the patient’s life.[14] Acute pain, without appropriate management, can lead to chronic pain through immunological and neurological changes.[19]
History
[edit]In 2009, a WHO report noted that accessing treatment for pain was difficult for many people in many places in the world for a range of reasons.[3][20]
References
[edit]- ^ * Brown, AK; Christo, PJ; Wu, CL (2004). "Strategies for postoperative pain management". Best Practice & Research: Clinical Anaesthesiology. 18 (4): 703–17. doi:10.1016/j.bpa.2004.05.004. PMID 15460554.
- Cullen, L; Titler, MG; Titler, MG (2001). "Pain management in the culture of critical care". Critical Care Nursing Clinics of North America. 13 (2): 151–66. doi:10.1016/S0899-5885(18)30046-7. PMID 11866399.
- Rupp, T; Delaney, KA (April 2004). "Inadequate analgesia in emergency medicine" (PDF). Annals of Emergency Medicine. 43 (4): 504–6. doi:10.1016/j.annemergmed.2003.11.019. PMID 15039693.
- Smith, GF; Toonen, TR (15 Apr 2007). "Primary care of the patient with cancer". American Family Physician. 75 (8): 1207–14. PMID 17477104.
- Jacobson, PL; Mann, JD (2003). "Evolving role of the neurologist in the diagnosis and treatment of chronic noncancer pain". Mayo Clinic Proceedings. 78 (1): 80–4. doi:10.4065/78.1.80. PMID 12528880.
- Deandrea, S; Montanari, M; Moja, L; Apolone, G. (2008). "Prevalence of undertreatment in cancer pain. A review of published literature". Annals of Oncology. 19 (12): 1985–91. doi:10.1093/annonc/mdn419. PMC 2733110. PMID 18632721.
- Okuyama, T; Wang, XS; Akechi, T; Mendoza, TR; Hosaka, T; Cleeland, CS; Uchitomi, Y; et al. (2004). "Adequacy of cancer pain management in a japanese cancer hospital" (PDF). Japanese Journal of Clinical Oncology. 34 (1): 37–42. doi:10.1093/jjco/hyh004. PMID 15020661.
- Perron, V; Schonwetter, RS (Jan–Feb 2001). "Assessment and management of pain in palliative care patients" (PDF). Cancer Control. 8 (1): 15–24. doi:10.1177/107327480100800103. PMID 11176032. Archived from the original (PDF) on 2008-07-12.
- ^ * Selbst, SM; Fein, JA (2006). "Sedation and analgesia". In Fleisher, GR; Ludwig, S; Henretig, FM (eds.). Textbook of pediatric emergency medicine (5 ed.). Philadelphia: Lippincott Williams & Wilkins. p. 63. ISBN 978-0-7817-5074-5.
- Kohen, D. P. (2001). Applications of clinical hypnosis with children (PDF). pp. 309–325. doi:10.1002/0470846402.ch22. ISBN 978-0471970095.
{{cite book}}
:|journal=
ignored (help) - Taylor, BJ; Robbins, JM; Gold, JI; Logsdon, TR; Bird, TM; Anand, KJ; et al. (2006). "Assessing postoperative pain in neonates: A multicenter observational study". Pediatrics. 118 (4): e992–e1000. doi:10.1542/peds.2005-3203. PMID 17015519.
- Cleeland, CS (1998). "Undertreatment of cancer pain in elderly patients". Journal of the American Medical Association. 279 (23): 1914–5. doi:10.1001/jama.279.23.1914. PMID 9634265.
- Kohen, D. P. (2001). Applications of clinical hypnosis with children (PDF). pp. 309–325. doi:10.1002/0470846402.ch22. ISBN 978-0471970095.
- ^ a b Medicines Access and Rational Use (February 2009), Access to Controlled Medications Programme - Improving access to medications controlled under international drug conventions (PDF), Department of Essential Medicines and Pharmaceutical Policies Health Systems and Services, World Health Organization, retrieved 28 July 2016
- ^ a b Human Rights Watch, "Please, do not make us suffer any more..." Access to Pain Treatment as a Human Right, March 2009
- ^ a b Pillay, Thivian Kandasamy; van Zyl, Hendrik Adriaan; Blackbeard, David Roy (January 2, 2014). "The Influence of Culture on Chronic Pain: A Collective Review of Local and International Literature" (PDF). Journal of Psychiatry. 18.
- ^ a b "Pain, citizenship, and invisibility: A response to Joanna Kempner". Social Science & Medicine. 189: 155–157. 2017-09-01. doi:10.1016/j.socscimed.2017.07.022. ISSN 0277-9536.
- ^ a b Racine, Melanie; Tousignant-Laflamme, Yannick; Kloda, Lorie; Dion, Dominique; Dupuis, Gilles; Choinière, Manon (November 22, 2011). "A systematic literature review of 10 years of research on sex/gender and experimental pain perception – Part 1: Are there really differences between women and men?" (PDF). International Association for the Study of Pain. 153: 602–618.
- ^ a b c Green, Carmen R.; Anderson, Karen O.; Baker, Tamara A.; Campbell, Lisa C.; Decker, Sheila; Fillingim, Roger B.; Kaloukalani, Donna A.; Lasch, Kathyrn E.; Myers, Cynthia; Tait, Raymond C.; Todd, Knox H. (2003-09-01). "The Unequal Burden of Pain: Confronting Racial and Ethnic Disparities in Pain". Pain Medicine. 4 (3): 277–294. doi:10.1046/j.1526-4637.2003.03034.x. ISSN 1526-2375.
- ^ Mossey, Jana M. (July 2011). "Defining racial and ethnic disparities in pain management". Clinical Orthopaedics and Related Research. 469 (7): 1859–1870. doi:10.1007/s11999-011-1770-9. ISSN 1528-1132. PMC 3111792. PMID 21249483.
- ^ a b c Anderson, Karen O.; Green, Carmen R.; Payne, Richard (December 2009). "Racial and ethnic disparities in pain: causes and consequences of unequal care". The Journal of Pain. 10 (12): 1187–1204. doi:10.1016/j.jpain.2009.10.002. ISSN 1528-8447. PMID 19944378.
- ^ a b c d e f g h i j k l m "In excruciating pain, sickle cell patients are shunted aside". STAT. 2017-09-18. Retrieved 2021-04-04.
- ^ a b "A Review of the Literature on the Multiple Dimensions of Chronic Pain in Adults with Sickle Cell Disease". Journal of Pain and Symptom Management. 40 (3): 416–435. 2010-09-01. doi:10.1016/j.jpainsymman.2009.12.027. ISSN 0885-3924 – via Elsevier Science Direct.
- ^ a b c d Lee, LaTasha; Smith-Whitley, Kim; Banks, Sonja; Puckrein, Gary (2019-11-01). "Reducing Health Care Disparities in Sickle Cell Disease: A Review". Public Health Reports. 134 (6): 599–607. doi:10.1177/0033354919881438. ISSN 0033-3549. PMC 6832089. PMID 31600481.
{{cite journal}}
: CS1 maint: PMC format (link) - ^ a b c d e f g Sinatra, Raymond (2010-12-01). "Causes and Consequences of Inadequate Management of Acute Pain". Pain Medicine. 11 (12): 1859–1871. doi:10.1111/j.1526-4637.2010.00983.x. ISSN 1526-2375.
- ^ a b c "Effort To Control Opioids In An ER Leaves Some Sickle Cell Patients In Pain". NPR.org. Retrieved 2021-04-04.
- ^ Galvez, Rafael (2009-12-03). "Variable Use of Opioid Pharmacotherapy for Chronic Noncancer Pain in Europe: Causes and Consequences". Journal of Pain & Palliative Care Pharmacotherapy. 23 (4): 346–356. doi:10.3109/15360280903323665. ISSN 1536-0288.
- ^ a b Dureja, Gur Prasad; Iyer, Rajagopalan N.; Das, Gautam; Ahdal, Jaishid; Narang, Prashant (2017-03-29). "Evidence and consensus recommendations for the pharmacological management of pain in India". Journal of Pain Research. doi:10.2147/jpr.s128655. PMC 5386610. PMID 28435313. Retrieved 2021-04-07.
{{cite web}}
: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ García, César Amescua; Santos Garcia, Joao Batista; Rosario Berenguel Cook, María del; Colimon, Frantz; Flores Cantisani, José Alberto; Guerrero, Carlos; Rocío Guillén Núnez, María del; Hernández Castro, John Jairo; Kraychete, Durval Campos; Lara-Solares, Argelia; Lech, Osvandré (2018-05-01). "Undertreatment of pain and low use of opioids in Latin America". Pain Management. 8 (3): 181–196. doi:10.2217/pmt-2017-0043. ISSN 1758-1869.
- ^ a b c King, Nicholas B.; Fraser, Veronique (2013-04-02). "Untreated Pain, Narcotics Regulation, and Global Health Ideologies". PLoS Medicine. 10 (4): e1001411. doi:10.1371/journal.pmed.1001411. ISSN 1549-1676. PMC 3614505. PMID 23565063.
{{cite journal}}
: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ Human Rights Watch (2 June 2011), Global State of Pain Treatment: Access to Medicines and Palliative Care, Human Rights Watch, retrieved 28 July 2016